Rekah Pharmaceutical Industry Ltd.

TASE:REKA Stock Report

Market Cap: ₪163.6m

Rekah Pharmaceutical Industry Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of REKA?
Owner TypeNumber of SharesOwnership Percentage
Institutions328,6062.88%
General Public1,542,33813.5%
Individual Insiders4,627,90840.5%
VC/PE Firms4,915,78443.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 13 shareholders own 86.49% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.1%
First Israel Mezzanine Investors Ltd.
4,915,784₪70.4m0%2.46%
15.3%
Mordechai Elgrabli
1,748,439₪25.1m0%no data
15.3%
Georgette Elgrabli
1,748,439₪25.1m0%no data
7.09%
Udi Dor
809,770₪11.6m0%no data
2.79%
Helen Dor
318,259₪4.6m0%no data
1.78%
Yelin Lapidot Holdings Ltd.
203,425₪2.9m-1.23%0.03%
0.98%
I.B.I Mutual Funds Management (1978) Ltd.
111,853₪1.6m0%0.04%
0.093%
Phoenix Investments & Finances Ltd
10,620₪152.2k0%no data
0.026%
Yaakov Elgrabli
3,001₪43.0k0%no data
0.016%
Meitav Investment House Ltd
1,785₪25.6k-1.6%no data
0.0047%
Migdal Mutual Funds Ltd.
539₪7.7k6.52%no data
0.0021%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
244₪3.5k0%no data
0.0012%
Psagot Index Funds Ltd
140₪2.0k0%no data